Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study

Abitbol Alexander; Brown Ruth E.; Jiandani Dishay; Sauriol Luc; Aronson Ronnie

首页> 外文期刊>Canadian journal of diabetes >Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study

【24h】

Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study

机译：胰岛素胰岛素的现实健康结果300 U / ml对胰岛素冰壶100 u / ml在1型和Canadian LMC糖尿病患者登记处的2型和2型糖尿病患者：现实研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: This study evaluated real-world clinical outcomes of patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) initiating or transferring to insulin glargine 300 U/mL (Gla-300) vs insulin glargine 100 U/mL (Gla-100).

机译：目的：本研究评估了1型糖尿病（T1D）和2型糖尿病（T2D）的现实世界临床结果（T2D），引发或转移到胰岛素冰柱300u / ml（GLA-300）Vs胰岛素龟甲100 U / ml（GLA -100）。

著录项

来源
《Canadian journal of diabetes》 |2019年第7期|共7页
作者
Abitbol Alexander; Brown Ruth E.; Jiandani Dishay; Sauriol Luc; Aronson Ronnie;
展开▼
作者单位

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON M4G 3E8 Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON M4G 3E8 Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON M4G 3E8 Canada;

Sanofi Canada Laval PQ Canada;

LMC Diabet &

Endocrinol 1929 Bayview Ave Toronto ON M4G 3E8 Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
diabetes mellitus; glycemic control; hemoglobin A1C; insulin glargine; real-world evidence; retrospective cohort;

机译：糖尿病;血糖控制;血红蛋白A1C;胰岛素冰壶;现实世界的证据;回顾性队列;

相似文献

外文文献
中文文献
专利

1. Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study [J] . Abitbol Alexander, Brown Ruth E., Jiandani Dishay, Canadian journal of diabetes . 2019,第7期

机译：胰岛素胰岛素的现实健康结果300 U / ml对胰岛素冰壶100 u / ml在1型和Canadian LMC糖尿病患者登记处的2型和2型糖尿病患者：现实研究
2. COST-UTILITY EVALUATION OF INSULIN GLARGINE 300 (GLA-300) VERSUS INSULIN GLARGINE 100 (GLA-100) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) [J] . Delgado M., Rubio M., Gasche D., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：2型糖尿病（T2DM）患者的胰岛素GLARGINE 300（GLA-300）相对于胰岛素GLARGINE 100（GLA-100）的成本效用评估
3. Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real-world results from the DELIVER Naive cohort study [J] . Bailey Timothy S., Zhou Fang L., Gupta Rishab A., Diabetes, obesity & metabolism . 2019,第7期

机译：2型糖尿病患者的血糖目标达到和低血糖结果引发胰岛素狼犬300个单位/ ml或100单位/ ml：现实世界结果来自交付天真的队列研究
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3 [O] . Jean-François Yale, Jeremy Hodson Pettus, Miguel Brito-Sanfiel, -1

机译：联合使用DPPIVi对2型糖尿病患者血糖控制为300 U / mL（Gla-300）与甘精胰岛素100 U / mL（Gla-100）的血糖控制和低血糖的影响：一项针对患者的荟萃分析第2版和第3版
7. Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study [O] . Alexander Abitbol, Ruth E. Brown, Dishay Jiandani, 2019

机译：胰岛素胰岛素的现实健康结果300 U / ml对胰岛素冰壶100 u / ml在1型和Canadian LMC糖尿病患者登记处的2型和2型糖尿病患者：现实研究

Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study

摘要

著录项

相似文献

相关主题

期刊订阅